World's Best Scientists 2026 revealed!

Cissy Kityo publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Cissy Kityo sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

The last bar groups every scientist with 679 publications or more.

Cissy Kityo D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Cissy Kityo sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

The last bar groups every scientist with 127 D-Index or more.

Overview

Cissy Kityo is affiliated with the Joint Clinical Research Centre in Uganda. Their research primarily focuses on fields related to medicine, particularly infectious diseases and immunology and microbiology. Within these domains, their subfields of study include infectious diseases, virology, emergency medicine, epidemiology, and cardiology and cardiovascular medicine.

The scientist's work covers several main topics, including HIV research and treatment, HIV/AIDS research and interventions, HIV/AIDS drug development and treatment, HIV-related health complications and treatments, hepatitis C virus research, Pneumocystis jirovecii pneumonia detection and treatment, and SARS-CoV-2 and COVID-19 research.

Frequent coauthors collaborating with Cissy Kityo include Rashidah Nazzinda, Chris T. Longenecker, Moherndran Archary, Adeodata Kekitiinwa, and Diana M. Gibb.

Their research has been published repeatedly in notable venues such as AIDS, The Lancet HIV, Clinical Infectious Diseases, bioRxiv (Cold Spring Harbor Laboratory), and SSRN Electronic Journal.

Significant recent papers authored or coauthored by Cissy Kityo are:

  • Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021, 2021, Nature Medicine
  • Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV, 2021, New England Journal of Medicine
  • Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial, 2022, The Lancet HIV
  • A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial, 2022, The Lancet. Gastroenterology & hepatology
  • Quantifying HIV transmission flow between high-prevalence hotspots and surrounding communities: a population-based study in Rakai, Uganda, 2020, The Lancet HIV

Best Publications

  • A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency Virus

    Whalen Cc;Johnson Jl;Okwera A;Hom Dl

  • Depletion of Regulatory T Cells in HIV Infection Is Associated with Immune Activation

    Mark P. Eggena;Banson Barugahare;Norman Jones;Martin Okello

  • Defining total-body AIDS-virus burden with implications for curative strategies

    Jacob D. Estes;Cissy Kityo;Francis Ssali;Louise Swainson

  • Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting.

    Jessica H. Oyugi;Jayne Byakika-Tusiime;Edwin D. Charlebois;Cissy Kityo

  • Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.

    Steven G. Deeks;Nancie Archin;Paula Cannon;Simon Collins

  • Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda.

    Jessica H Oyugi;Jayne Byakika-Tusiime;Kathleen Ragland;Oliver Laeyendecker

  • HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study

    Raph L Hamers;Carole L Wallis;Cissy Kityo;Margaret Siwale

  • Effect of pretreatment HIV-1 drug resistance on immunological virological and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study.

    Raph L. Hamers;Rob Schuurman;Kim C.E. Sigaloff;Carole L. Wallis

  • Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa

    Nicholas I. Paton;Cissy Kityo;Anne Hoppe;Andrew Reid

  • Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa

    Kim C E Sigaloff;Raph L Hamers;Carole L Wallis;Cissy Kityo

  • Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa.

    J Hakim;V Musiime;AJ Szubert;J Mallewa

  • Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults.

    John L. Johnson;Alphonse Okwera;David L. Hom;Harriet Mayanja

  • Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies

    Raph L. Hamers;Kim C. E. Sigaloff;Annemarie M. Wensing;Carole L. Wallis

  • Severe Renal Dysfunction and Risk Factors Associated with Renal Impairment in HIV-Infected Adults in Africa Initiating Antiretroviral Therapy

    Andrew Reid;Wolfgang Stöhr;A. Sarah Walker;Ian G. Williams

  • Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa

    P. Kaleebu;D. Pillay;A. S. Walker;V. Robertson

  • Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects.

    Jessica E. Haberer;Adrian Cook;A. Sarah Walker;Marjorie Ngambi

  • Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda.

    Scott Robert Penzak;G. Kabuye;P. Mugyenyi;F. Mbamanya

  • Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV.

    Nicholas I Paton;Joseph Musaazi;Cissy Kityo;Stephen Walimbwa

  • Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial.

    Unknown

  • Antiretroviral therapy and sexual behavior: A comparative study between antiretroviral-naive and -experienced patients at an urban HIV/AIDS care and research center in Kampala, Uganda

    Moses Bateganya;Grant Colfax;Leigh Anne Shafer;Cissy Kityo

  • A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis: A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosis

    S. Schwander;S. Rüsch-Gerdes;A. Mateega;T. Lutalo

  • T Cell Activation in HIV-Seropositive Ugandans: Differential Associations with Viral Load, CD4+ T Cell Depletion, and Coinfection

    Mark P. Eggena;Banson Barugahare;Martin Okello;Steven Mutyala

  • Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.

    Francis Ssali;Wolfgang Stöhr;Paula Munderi;Andrew Reid

  • Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa.

    T. Sonia Boender;Cissy M. Kityo;Ragna S. Boerma;Raph L. Hamers

Frequent Co-Authors

Peter Mugyenyi
Peter Mugyenyi Uganda National Academy of Sciences
Charles F. Gilks
Charles F. Gilks University of Queensland
Diana M. Gibb
Diana M. Gibb University College London
Tobias F. Rinke de Wit
Tobias F. Rinke de Wit University of Amsterdam
Grace A. McComsey
Grace A. McComsey Case Western Reserve University
Wendy S. Stevens
Wendy S. Stevens National Health Laboratory Service
Eric J. Arts
Eric J. Arts University of Western Ontario
Rob Schuurman
Rob Schuurman Utrecht University
David Dunn
David Dunn University College London
Robert Colebunders
Robert Colebunders University of Antwerp

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a variety of career paths beyond traditional lab roles. Many professionals leverage their background in biological sciences to further specialize in healthcare fields. For instance, becoming a functional medicine nurse practitioner combines microbiology knowledge with patient-centered healthcare, emphasizing holistic treatment approaches.

Another important sector linked to microbiology graduates is health data management. With the growing importance of healthcare information, roles like Certified Professional Coders (CPC) are in high demand. Earning a certification as a certified professional coder (cpc) allows professionals to accurately manage medical coding and billing, an essential part of healthcare administration.

For those interested in broader organizational roles, exploring careers in health information management is a strong option. Understanding data systems and compliance can lead to lucrative opportunities in health information management jobs salary and career advancements.

To kickstart these career pathways, choosing the right educational programs is crucial. Prospective students should consider enrolling in top-ranked best cahiim accredited him programs online, which offer quality coursework and flexibility for those balancing work and study.

Best Scientists Citing Cissy Kityo

Trending Scientists